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Opioid Use After Open Resection or Video-Assisted Thoracoscopic Surgery for Early-Stage Lung Cancer
Patients undergoing surgery for early-stage lung cancer often experience persistent postoperative pain; it has been estimated that in 10% of patients the pain can be so intense as to be debilitating. 1 While the current standard of care is to prescribe opioids at discharge, this treatment is intended as shortterm pain control, not to exceed a few weeks after surgery. Patients who underwent VATS were more likely to be women; older; have a smaller tumor, adenocarcinoma, limited resection, and a lower comorbidity score; belong to a higher income quartile; and live in an urban area. Patients who underwent VATS were significantly less likely to have filled an opioid prescription within 90 days after surgery, had a smaller number of overall opioid prescriptions filled than open resection patients, and were less likely to be long-term opioid users ( Table 1) .
In the adjusted model, patients were significantly less likely to use opioids long-term if they had VATS (adjusted odds ratio [aOR], 0.69; 95% CI, 0.57-0.84), were older (aOR, 0.96, 95% CI 0.94-0.98), and had higher income (aOR, 0.77, 95% CI 0.60-0.99). Long-term opioid use was significantly more likely in those with a higher comorbidity score (aOR, 1.10; 95% CI, 1.05-1.16), large-cell histology (aOR, 1.88; 95% CI, 1.17-3.00), using sleep medication 30 days before surgery (aOR, 1.72; 95% CI, 1.28-2.32), and with a previous psychiatric condition (aOR, 1.64; 95% CI, 1.28-2.09). After propensity matching, the risk of longterm opioid use was still significantly less in patients who underwent VATS (aOR, 0.52; 95% CI, 0.36-0.75) ( Table 2) .
Discussion | A total of 15.5% of patients who were not previous opioid users became long-term opioid users after surgery. Our study suggests that surgical invasiveness might play a role in the odds of becoming a long-term opioid user after surgery; patients undergoing VATS were less likely to use opioids both in the immediate postoperative period and long-term, even after adjusting for relevant covariates. A limitation of this claimbased study is the precision of the measurement: we cannot discount, for example, that patients may have been able to acquire opioids from friends or family members. However, this possibility suggests that we are likely underestimating the true proportion of long-term opioid users. The escalating severity of the opioid epidemic in the United States 6 highlights the need for additional research into how pain management after sur
Erectile Dysfunction in Male Survivors of Childhood Cancer
Male sexual dysfunction and its association with psychological and physical well-being have been underreported in childhood cancer survivors (CCSs). To our knowledge, this study provides the first data on a large population of systematically and clinically assessed CCSs, enumerating the prevalence and consequences of erectile dysfunction (ED) and identifying potential targets for intervention.
Methods | This cross-sectional, single-institution study included male CCSs, 18 years or older, 10 years or more from diagnosis of childhood cancer who completed questionnaires on sexual health. 1 In sexually active participants, mild to severe ED was defined by scores of 25 or less, using the 
